EQL PHARMA AB (7JK) — Free Cash Flow Generation Index
EQL PHARMA AB (7JK) has a Free Cash Flow Generation Index of 0.12x as of December 2025. Free cash flow of €1.57 Million represents 0% of operating cash flow (€13.44 Million). See EQL PHARMA AB working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
EQL PHARMA AB Free Cash Flow Generation Index (2022–2023)
Historical FCF Generation Index trend for EQL PHARMA AB across 2 annual periods. Explore 7JK operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for EQL PHARMA AB (2022–2023)
Year-by-year Free Cash Flow Generation Index for EQL PHARMA AB. For the full company profile including market capitalisation, see how much is EQL PHARMA AB worth.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.26x | €7.11 Million | €27.62 Million | €20.51 Million | ▼ -45.5% |
| 2022 | 0.47x | €19.74 Million | €41.83 Million | €22.09 Million | — |